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Background: Herpes simplex virus (HSV) has been shown to cause respiratory tract infections mostly in severely
immunocompromised patients. Endobronchial tumor-like lesions have been described very rarely as HSV pulmonary
manifestations in critically ill patients or in immunosuppressed individuals.
Case presentation: This case study describes a 75-yr-old male who presented with persistent hoarseness.
Fiberoptic bronchoscopy showed marked mucosal thickening protruding in mid and distal trachea causing stenosis.
Biopsy specimens demonstrated cytopathological changes consistent with HSV type 1 and 2 infection.
Conclusions: To the best of the authors’ knowledge, this is the first reported case of HSV presenting as an
endotracheal tumor in an immunocompetent person.
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Herpes simplex virus (HSV) can cause tracheobronchitis
and pneumonitis mostly in severely immunocomprom-
ised patients [1,2]. Endobronchial tumor has very rarely
been reported as a clinical presentation of HSV in critic-
ally ill patients or in individuals with conditions leading
to impaired immunity [3,4]. However, this rare clinical
manifestation has not been described in normal hosts.
Herein, we present the first case, to our knowledge, of
endo-tracheal tumor caused by HSV infection in an im-
munocompetent person.Case presentation
A 75-year old male, heavy smoker (70 p/y), was referred to
our department for evaluation of persistent hoarseness
and associated non-productive cough. He reported the on-
set of these symptoms two months before his admission.
His past medical history included arterial hypertension,
hypercholesterolaemia and a resected basal cell skin car-
cinoma of the neck. He was receiving daily atorvastatin
(20 mg), ezetimibe (10 mg) and valsartan plus hydrochlo-
rothiazide (80 +12.5 mg). Additionally, he did not mention* Correspondence: skatsenos@yahoo.gr
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intake.
Chest examination revealed diffuse expiratory wheez-
ing. The rest of physical examination was unremarkable.
Initial laboratory testing was normal except for a slightly
increased erythrocyte sedimentation rate (35 mm/h) and
C-reactive protein (2.5 mg/dl). Standard serum biochemis-
try tests were within normal range. Spirometry showed
decreased FEV1, FVC, FEF25–75% (57, 63 and 28% of pre-
dicted values), increased FEV1/FVC ratio (93% of pre-
dicted value) and normal FIVI thus representing a
moderate restriction with associated small airways ob-
struction. Arterial blood gases while breathing room air
showed mild hypoxemia (PaO2: 70 mmHg, PaCO2:
37 mmHg, pH: 7.44 and bicarbonate: 27.5 mmol/l). Chest
computed tomography showed mid and distal trachea
lumen stenosis. No lesion was noted in the lung
parenchyma.
Fiberoptic bronchoscopy demonstrated prominent mu-
cosal thickening at the left false and true vocal cord and
the anterior commissure of glottis (Figure 1A), as well as
irregular and mucosal surfaces protruding in mid and
lower third of the trachea resulting in lumen stenosis
(Figure 1B). Biopsies showed tracheal mucosa fragments
that were lined by thickened squamous epithelium with
mild hyperplasia and atypia and slight increase of mi-
totic activity in its basal half. There was no evidence ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A Fiberoptic bronchoscopy showing prominent
mucosal thickening at the left false and true vocal cord and the
anterior commissure of glottis. B. Irregular and mucosal surfaces
protruding in mid and lower third of the trachea.
Figure 2 Tracheal biopsy showing intranuclear inclusions
(haematoxylin and eosin stain [H&E], original
magnification X400).
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intranuclear inclusions typical of herpes virus (Figure 2).
Similar findings were found in biopsies from lesions of
vocal cords. Molecular testing using polymerase chain
reaction (PCR) identified HSV type 1 in tissue speci-
mens. Based on histopathology results, the patient re-
ceived intravenous acyclovir (5 mg/kg every 8 hours) for
7 days followed by oral drug administration for the next
two weeks. Three months after the completion of treat-
ment, a repeat fiberoptic bronchoscopy showed subs-
tantial regression of the laryngeal and tracheal lesions.
No evidence of HSV infection was noted in multiple bi-
opsy specimens. The patient’s voice improved and an-
nual bronchoscopic examination was recommended.
Discussion
Primary infection with HSV and its reactivation usually
occur in immunocompromised patients. Therefore, herpetictracheobronchitis and pneumonia as pulmonary manifes-
tations have been reported in patients with malignancy,
burns, organ transplantation, AIDS or patients receiving
corticosteroids [1]. Moreover, herpes tracheobronchitis
and bronchopneumonia have been described in immuno-
competent patients, particularly in the elderly as well as in
non-immunocompromised patients requiring mechanical
ventilation [2,3].
Herpes simplex viruses (HSV-1, HSV-2) have been
identified as causative agents of lower respiratory tract
infections, such as tracheobronchitis and pneumonia.
The precise disease mechanism involved is not clearly
understood. However, it has been postulated that the
virus may reach the lower respiratory tract by aspiration
or by contiguous spread after reactivation and shedding
in the oropharynx. The presence of macroscopic bron-
chial lesions, possibly due to local microtrauma and/or
pre-existing acute lung injury with distal squamous cell
metaplasia, might also have paved the way for distal in-
fection. Thus, local distal reactivation as another mech-
anism cannot be unequivocally excluded [3].
Although HSV can be cultured from sputum, diagnosis
of HSV infection is feasible from the characteristic cyto-
logical and histological findings seen in samples obtained
by bronchoscopic examination [1]. More specifically, the
presence of intranuclear inclusions is considered to be
useful cytopathic feature, albeit less sensitive. Further-
more, HSV can be detected by virus culture or quantita-
tively by nucleic acid amplification techniques. While
viral cultures are difficult to handle, PCR has become
the most popular diagnostic tool since it is easily
performed. In the present case, histological findings as
well as molecular testing using PCR were confirmatory
of HSV infection.
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simulating neoplasm have been reported in immunocom-
promised patients [4,5]. In particular, the first case de-
scribes a HIV-infected patient who presented with
ulcerative tracheobronchitis and a cauliflower-like lesion
occluding the right upper lobe bronchus. The second case
study refers to a patient with severe kyphoscoliosis who
was intubated for acute on chronic hypercapnic respira-
tory failure due to community-acquired pneumonia.
Fiberoptic bronchoscopy demonstrated an endobronchial
mass in the right middle lobe. Cultures and biopsy speci-
mens demonstrated HSV-1 infection. The endotracheal
tumor-like lesions of the patient presented here may have
resulted from reactivation of latent infection, because he
had HSV-positive serology (IgG without IgM) at the time
of diagnosis.
Conclusion
This is the first reported case, to our knowledge, of HSV
type I infection presenting with tracheal tumor-like lesions
to generate awareness that this entity may masquerade
neoplasm even in the immunocompetent patient.
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